-
The continuing adoption of electronic medical records (EMRs) might result in increased malpractice liability risk and higher insurance premiums, according to a new report from a health IT research firm.
-
A physician complained to the chief of staff and hospital management that surgical equipment is not being sterilized properly and a patient died as a result. In another case, two doctors reported overcrowding in the emergency department that compromised patient care. In another, the physician reported an unlicensed therapy program.
-
An 85-year-old woman underwent surgery for an aortofemoral bypass at a local medical center in 2004. In the four years following the surgery, the patient suffered from periodic severe abdominal and back pain, a foul odor coming from her body, weakness, lightheadedness, dizziness, loss of appetite, and nausea.
-
Memorial Health System in Springfield, IL, provides this statement regarding the physician who claims he was placed on leave for failing to adequately adapt to the system's new electronic medical record (EMR):
-
Improving the readability of informed consent involves more than a one-time education of researchers or IRB staff it's a process that requires ongoing commitment.
-
As genetic testing becomes better able to pinpoint risk factors for various diseases, is there potential harm to subjects in giving them test results, particularly when there are limited treatment and prevention options?
-
A new study looks at an intriguing strategy for improving study subjects' understanding and knowledge of clinical research.
-
Transitioning to an electronic submission process is challenging. It also is a time when IRBs need to pay close attention to current compliance practices with an eye on updating standard operating procedures to reflect the new electronic practices and processes.
-
As the human research protection program at Mount Sinai Medical Center prepared for accreditation in 2010, IRB Manager Stacy Chandna says she and her colleagues knew they had a daunting task ahead.
-
In the fight against Alzheimer's disease dementia, researchers have long targeted beta-amyloid plaques, accumulated protein fragments in the brain that are a hallmark of the disease. The plaques are believed to contribute to the cognitive impairment associated with Alzheimer's disease.